secwatch / observer
8-K filed December 8, 2025, 6:59 PM ET ticker DROR CIK 0001282980
debt confidence high sentiment neutral materiality 0.25

Dror Ortho-Design raises $200,000 via 0% debentures due Feb 2026, convertible upon public offering

Dror Ortho-Design, Inc.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Dror Ortho-Design, Inc. issued convertible note to accredited investors for aggregate principal amount of $200,000.

Security
convertible note
Purchaser
accredited investors
Consideration
aggregate principal amount of $200,000
Exact text from the filing
Agreement, the Company agreed to sell to the Purchasers in a private placement (the “Private Placement”), Debentures (the “Debentures”) in an aggregate principal amount of $200,000 due February 2, 2026 (the “Maturity Date”). In addition, pursuant to the Purchase Agreement the Company agreed to issue (A) subject to the consummation of a public offering by
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Dror Ortho-Design, Inc. entered into Securities Purchase Agreement with the Purchasers valued at $200,000 (effective 2025-12-02).

Action
entry
Agreement
equity purchase
Counterparty
the Purchasers
Value
$200,000
Effective
2025-12-02
Exact text from the filing
On December 2, 2025, Dror Ortho-Design, Inc. (the “Company”), a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers signatory thereto (each, a “Purchaser” and, collectively the “Purchasers”).
View on SEC.gov

Browse all equity issuances →

Dror Ortho-Design, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-25-119227
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.